December 08, 2015
Apotex Inc. infringed Takeda and AstraZeneca's patent for the chronic obstructive pulmonary disease drug Daliresp with a filing to the U.S. Food and Drug Administration declaring its intent to market a generic, according to a lawsuit filed Monday in New Jersey federal court.